Before the science took over, myths ran the show. Time to fix that.
You’ve probably heard at least one of these:
“Cancer is just bad
luck.” “Sugar feeds cancer.” “It runs in families, so nothing can be done.”
Some of these contain
a sliver of truth. Most are dangerously incomplete. These fragments are not the
story - they are shadows cast by a far deeper one. The reality of why a healthy
cell decides to stop following the rules is stranger, and more fascinating,
than any folk wisdom suggests.
Over the past five decades, a handful of papers published in the most
rigorous journals on the planet have peeled back the curtain on cancer’s true
origins. Here are five of them - and one unsettling update from 2026.
Paper 1 - The Blueprint
Imagine cancer not as
a single disease but as a set of behaviors a cell learns to acquire.
That’s precisely what Douglas Hanahan and Robert Weinberg argued in this
monumental paper - one of the most cited in all of biology.
Their central
insight: no matter where a cancer originates, it must acquire the same six core
capabilities - generating its own growth signals, ignoring stop signals,
evading programmed cell death (apoptosis), replicating without limit,
building a private blood supply (angiogenesis), and invading other
tissues.
Before this paper,
researchers were drowning in isolated facts. After it, there was a unified
grammar for cancer. Every mutation, every carcinogen, every malignant trick
maps back to at least one of these hallmarks.
What makes the story even better is how the paper came to exist.
Weinberg told Ludwig Cancer Research:
“Writing The
Hallmarks of Cancer was an accident. Doug Hanahan and I were playing hooky one
afternoon from a conference in Hawaii, and we were walking down the mouth of a
volcano when we began to talk about the fact that, unlike the laws of physics,
the laws of cancer biology were quite messy and not clearly conceptualized… We
wrote the review in 1999 fully expecting that, like most reviews, it would sink
like a stone thrown into a quiet pond. To our surprise, indeed total
astonishment, it turned out to be very helpful.”
A lazy afternoon on a volcano. One of the most influential papers in the history of medicine.
The takeaway: If you want to understand why a cell goes rogue, this is the map.
Figure 1.
The six hallmarks of cancer as defined by Hanahan & Weinberg (Cell, 2000),
illustrating the core capabilities a cell must acquire to become malignant - from self-sufficient growth signaling to tissue invasion. AI-generated
illustration; created for educational purposes. Not to be reproduced without
attribution.
Paper 2 - The Broken Brake: Knudson’s Two-Hit Hypothesis
Alfred Knudson
noticed a pattern that didn’t add up. Children with hereditary retinoblastoma - a childhood eye cancer - developed tumors in both eyes, early in life. Sporadic
cases? One eye, much later.
In a spare
statistical analysis, Knudson proposed that cancer requires two genetic hits.
Hereditary patients are born with one already in place; one more is enough.
Sporadic patients must acquire both from scratch - hence the delay and the
single tumor.
This gave birth to
the tumor suppressor gene concept. Cells carry genes whose sole job is to
restrain growth - the molecular brakes. Cancer happens when both copies are
disabled. His prediction was confirmed with the cloning of RB1, the
retinoblastoma gene, and the same logic now applies to dozens of suppressors,
including TP53 - mutated in over half of all human cancers.
The takeaway: Cancer isn’t only about the gas pedal getting stuck. You also have to
lose the brakes.
Paper 3 - Darwin Inside You: “The Clonal Evolution of Tumor Cell Populations”
Peter Nowell put
forward an idea that sounded almost heretical: cancer is evolution. Not
metaphorically - literally Darwinian evolution, compressed inside a
single human body.
A single cell
acquires a mutation. If that mutation offers even a slight growth advantage,
its descendants outcompete their neighbors. New mutations accumulate. Selection
picks winners. The fittest, most aggressive cells take over.
This explained
something that had long frustrated oncologists: why tumors become resistant to
treatment. They evolve. Kill 99% of cells and the surviving 1% was already
resistant. It’s why no two patients’ tumors are quite identical, and why cancer
can return as a different beast than the one you treated.
The takeaway: You can’t treat cancer like a static target. It moves. It adapts. It
fights back.
Paper 4 - The Recipe: “A Genetic Model for Colorectal Tumorigenesis”
One mutation doesn’t
cause cancer. That was the quiet bombshell in this 1990 paper, which
reconstructed cancer’s recipe by tracking specific mutations in human colon
tissue at each stage - from benign polyp to invasive carcinoma. This roadmap is
now called the adenoma–carcinoma sequence.
The order is precise:
the tumor suppressor now known as APC is lost first, then the KRAS
proto-oncogene activates, then TP53 is disabled. Four or five driver
mutations, accumulating over years or decades, before a cell fully crosses the
line.
This reframed cancer
as a slow-building process rather than a sudden event, and explained why it is
predominantly a disease of age. More years means more chances to collect the
required hits. It also opened the door to interception: the colonoscopy is, in
essence, applied Fearon and Vogelstein.
The takeaway: Cancer is not a lightning strike. It’s slow accumulation - which means
there are windows to intervene.
Paper 5 — The Full Landscape: “Cancer Genome Landscapes”
By 2013, high-throughput sequencing made it possible to read the genomes of thousands of tumors at once. Vogelstein’s team did exactly that - and what they found reshaped the field.
They identified
approximately 140 cancer driver genes across human tumors. Crucially,
most cancers carry only two to eight actual driver mutations. The
remaining thousands of mutations are passengers — bystanders, not the
cause. And despite the surface diversity of cancer types, the same small set of
core pathways keeps breaking down: cell survival, genome integrity, cell fate
determination.
In a rare, published interview in the Journal of ClinicalInvestigation, Vogelstein put the purpose of it all plainly:
“Our end goal is not really publishing papers and making discoveries that turn out to be important. Our end goal is emptying the cancer center across the street in the hospital.”
The takeaway: The diversity of cancer is partly an illusion. Underneath, the same circuits keep failing.
The 2026 Update: Your Body’s Clock Is Part of the Equation
A landmark study
published in Nature Medicine in August 2026 (Tian et al.) added a new
dimension to everything above. Analyzing 154,169 adults from the UK Biobank,
the researchers found that biological aging - measured independently of
chronological age - has accelerated across birth cohorts. Those born
1965–1974 showed biological age scores 23% higher (by standard deviation) than
those born 1950–1954. That gap directly predicted early-onset cancer risk
(hazard ratio 1.08 per standard deviation), driven by lung, gastrointestinal,
and uterine cancers.
The mechanism went deeper still: accelerated immune aging predicted
early-onset lung cancer; accelerated adipose tissue aging predicted colorectal
cancer. The causes of cancer extend beyond your DNA sequence to how fast your
tissues age - and that rate appears shaped by environmental exposures acting on
entire generations.
The Full Picture
Cells don't go rogue randomly. They lose brakes, acquire growth signals,
accumulate driver mutations over decades, evolve under Darwinian selection, and
eventually collect enough capabilities to do whatever they want. The myths were
never entirely wrong - but they were looking at shadows on the wall.
These five papers turned on the lights. The goal, as Vogelstein put it,
is to empty the cancer ward - and in the next article, we'll look at whether
the science to actually do it is finally within reach.
See Also
The Counter-Revolution: Five Breakthroughs That Are Finally Taking the Fight to Cancer
Comments
Post a Comment